Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction: von Eyben et al. A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis. Cancers 2022, 14, 5461.
von Eyben R, Kapp DS, Hoffmann MA, Soydal C, Uprimny C, Virgolini I, Tuncel M, Gauthé M, von Eyben FE. von Eyben R, et al. Among authors: gauthe m. Cancers (Basel). 2023 Feb 7;15(4):1035. doi: 10.3390/cancers15041035. Cancers (Basel). 2023. PMID: 36831697 Free PMC article.
Restaging of Patients with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy Using [68Ga]-PSMA-11 Positron Emission Tomography/Computed Tomography: Impact on Disease Management.
Gauthé M, Sargos P, Benziane Ouaritini N, Barret E, Beauval JB, Brureau L, Créhange G, Dariane C, Fiard G, Fromont G, Mathieu R, Renard-Penna R, Roubaud G, Ruffion A, Rouprêt M, Ploussard G; Cancerology Committee of the French Association of Urology. Gauthé M, et al. Eur Urol. 2022 Apr;81(4):e87-e89. doi: 10.1016/j.eururo.2022.01.012. Epub 2022 Feb 4. Eur Urol. 2022. PMID: 35125228 No abstract available.
Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis.
Baboudjian M, Rajwa P, Barret E, Beauval JB, Brureau L, Créhange G, Dariane C, Fiard G, Fromont G, Gauthé M, Mathieu R, Renard-Penna R, Roubaud G, Ruffion A, Sargos P, Rouprêt M, Ploussard G; Prostate Cancer Committee of the Association Française d'Urologie CC-AFU. Baboudjian M, et al. Among authors: gauthe m. Eur Urol Open Sci. 2022 May 19;41:35-44. doi: 10.1016/j.euros.2022.04.012. eCollection 2022 Jul. Eur Urol Open Sci. 2022. PMID: 35633829 Free PMC article. Review.
How PET-CT is Changing the Management of Non-metastatic Castration-resistant Prostate Cancer?: Comment la TEP-TDM Peut Modifier la Prise en Charge du Cancer de la Prostate Non Métastatique Résistant à la Castration ?
Baboudjian M, Gauthé M, Barret E, Brureau L, Rocchi P, Créhange G, Dariane C, Fiard G, Fromont G, Beauval JB, Mathieu R, Renard-Penna R, Roubaud G, Ruffion A, Sargos P, Rouprêt M, Ploussard G. Baboudjian M, et al. Among authors: gauthe m. Prog Urol. 2022 Jun;32(6S1):6S43-6S53. doi: 10.1016/S1166-7087(22)00174-9. Prog Urol. 2022. PMID: 36719646 Review.
Micro-ultrasound-guided biopsies versus systematic biopsies in the detection of prostate cancer: a systematic review and meta-analysis.
Dariane C, Ploussard G, Barret E, Beauval JB, Brureau L, Créhange G, Fromont G, Gauthé M, Mathieu R, Renard-Penna R, Roubaud G, Ruffion A, Sargos P, Rouprêt M, Fiard G; Prostate Cancer Committee of the Association Française d’Urologie (CC-AFU). Dariane C, et al. Among authors: gauthe m. World J Urol. 2023 Mar;41(3):641-651. doi: 10.1007/s00345-022-04087-z. Epub 2022 Jul 14. World J Urol. 2023. PMID: 35835886 Free article.
What is the ideal combination therapy in de novo, oligometastatic, castration-sensitive prostate cancer?
Baboudjian M, Roubaud G, Fromont G, Gauthé M, Beauval JB, Barret E, Brureau L, Créhange G, Dariane C, Fiard G, Mathieu R, Ruffion A, Rouprêt M, Renard-Penna R, Sargos P, Ploussard G; Prostate Cancer Committee of the French Association of Urology. Baboudjian M, et al. Among authors: gauthe m. World J Urol. 2023 Aug;41(8):2033-2041. doi: 10.1007/s00345-022-04239-1. Epub 2022 Dec 9. World J Urol. 2023. PMID: 36484817 Review.
Narrative review of PET/CT performances at biochemical recurrence in prostate cancer after radical prostatectomy and impact on patient disease management: Revue narrative à propos des performances de la TEP/TDM en cas de récidive biochimique après prostatectomie radicale dans le cancer de la prostate et impact sur la prise en charge des patients.
Lasserre M, Sargos P, Barret E, Beauval JB, Brureau L, Créhange G, Dariane C, Fiard G, Fromont G, Mathieu R, Renard-Penna R, Roubaud G, Ruffion A, Rouprêt M, Ploussard G, Gauthé M; CC-AFU. Lasserre M, et al. Among authors: gauthe m. Prog Urol. 2022 Jun;32(6S1):6S33-6S42. doi: 10.1016/S1166-7087(22)00173-7. Prog Urol. 2022. PMID: 36719645 Review.
70 results